WEEKLY BRIEFING 1.22.21This week at RegentAtlantic we are talking about the coronavirus vaccine. Andy Kapyrin, Co-Head of Investments, discusses how the coronavirus vaccine may affect the markets in 2021.
WEEKLY BRIEFING 12.11.20This week at RegentAtlantic we are talking about the coronavirus vaccines. Co-Head of Investments Andy Kapyrin discusses how the coronavirus vaccines may affect the markets and what these vaccines could mean for the markets in the future.
WEEKLY BRIEFING 11.18.20WEEKLY BRIEFING 11.18.20 This week at RegentAtlantic, Co-Head of Investments Andy Kapyrin, talks about the news of a potential COVID-19 vaccine, its affect on the markets and the challenges that may lie ahead.
Partner and Co-Head of Investments
Andy is responsible for researching and analyzing valuations and market conditions, which help to inform RegentAtlantic’s asset allocation. A member of RegentAtlantic’s Investment Committee, Andy monitors and rebalances client portfolios. He is focused on the firm’s bond holdings, and is also responsible for trading, analyzing and helping to manage risk of clients’ corporate and municipal bond holdings. Andy produces on a quarterly basis the RegentAtlantic New Jersey Wealth Index (RANJWI), a proprietary index that measures the health of the wealth in New Jersey. Andy graduated with a BA in Economics and Political Science from Drew University, and is a Chartered Financial Analyst® Charterholder, and a member of the CFA Society New York. Andy was made partner at RegentAtlantic in 2010, just two years after joining the firm.